SCHEMBL6972923

SCHEMBL6972923

O=CC1c2ccccc2C=Cc2ccccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.45
CYP2D6 P10635 3/20 0.38
KDM4E B2RXH2 5/20 0.36
HSD17B10 Q99714 3/20 0.36
LMNA P02545 3/20 0.36
TP53 P04637 2/20 0.36
CYP3A4 P08684 2/20 0.36
RET P07949 2/20 0.36
BRD4 O60885 1/20 0.36
CCL2 P13500 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM1 P11229 1/20 0.36
DRD2 P14416 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
NFKB1 P19838 1/20 0.36
CHRM3 P20309 1/20 0.36
SLC6A2 P23975 1/20 0.36
HTR2C P28335 1/20 0.36
ADRA1A P35348 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5823531 0.87 CYP2D6 (0.41) HTR2ACYP2D6KDM4EHSD17B10LMNA
SCHEMBL7754656 0.82 MEN1 (0.38) KDM4EHSD17B10LMNATP53CYP3A4
Iodide SCHEMBL11463652 0.79 MEN1 (0.36) KDM4EHSD17B10LMNATP53CYP3A4
Hydrochloric Acid SCHEMBL11465934 0.79 MEN1 (0.36) KDM4EHSD17B10LMNATP53CYP3A4
SCHEMBL10481614 0.76 CYP2D6 (0.42) HTR2ACYP2D6KDM4EHSD17B10LMNA
SCHEMBL224931 0.75 GPR3 (0.41) HTR2ACYP2D6LMNAMEN1KMT2A
SCHEMBL29711937 0.75 GPR3 (0.41) HTR2ACYP2D6LMNAMEN1KMT2A
SCHEMBL28245592 0.74 TDP1 (0.34) LMNAMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL27818816 0.73 GPR3 (0.39) HTR2ACYP2D6MEN1KMT2AALDH1A1
Hydrochloric Acid SCHEMBL27768859 0.73 GPR3 (0.39) HTR2ACYP2D6MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1098893-B1 CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed
US-6528538-B1 Reaction of 1,3-propanediol derivative with a ketone or aldehyde MERCK PATENTGESELLSCHAFT (DE) 2003-03-04 US disclosed